
Boston Scientific is the corporate brand of Boston Scientific Corporation (NYSE: BSX), a publicly traded medical device company headquartered in Marlborough, Massachusetts. Founded in 1979, it sells cardiovascular, rhythm management, endoscopy, urology, and neuromodulation devices in more than 100 countries.
Parent Company
Founded
1979
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Boston Scientific | Boston Scientific Corporation | Brand division |
John Abele and Pete Nicholas founded the company as Medi-Tech in Watertown, Massachusetts in 1979, commercializing steerable catheters. Renamed Boston Scientific, it grew through the 1980s and 90s into an angioplasty and stent leader as interventional cardiology exploded.
The brand nearly broke in 2006, when a roughly $27 billion Guidant acquisition brought both a rhythm management business and crippling debt plus immediate product recalls. The company spent years divesting and recovering. Under Mahoney from 2011, it rebuilt through targeted deals: Atritech in 2011 (WATCHMAN), BTG in 2019 ($4.2 billion), Farapulse in 2021, Baylis in 2022, Relievant in 2023, and Silk Road Medical plus Axonics in 2024, followed by Bolt Medical and Nalu in 2025.
In 2026 the former growth engines stalled: US WATCHMAN sales fell 7% and electrophysiology declined amid pulsed field ablation competition and a cyber incident that hit manufacturing. Third quarter sales grew just 1.5% and guidance was cut three times, though neuromodulation grew 13% and newer platforms offset some weakness.
What does Boston Scientific make?
Interventional medical devices: coronary stents, catheters, pacemakers and defibrillators, the WATCHMAN appendage closure device, FARAPULSE ablation systems, endoscopy tools, urology implants, and neuromodulation stimulators.
Is Boston Scientific publicly traded?
Yes. It trades on the NYSE under ticker BSX and is a member of the S&P 500.
Who founded Boston Scientific?
John Abele and Pete Nicholas founded the company in 1979 in Watertown, Massachusetts as Medi-Tech. Mike Mahoney has served as CEO since 2011 and also chairs the board.
Why did Boston Scientific cut guidance in 2026?
US sales of WATCHMAN declined 7% amid a left atrial appendage closure market slowdown, electrophysiology faced tougher competition, China procurement cut prices, and a cyber incident disrupted manufacturing, together forcing three guidance reductions.
What companies has Boston Scientific acquired recently?
Recent deals include Axonics (2024, ~$3.7 billion), Silk Road Medical (2024, ~$1.26 billion), Relievant (2023, ~$850 million), and Bolt Medical and Nalu Medical in 2025.
Guidant recalls (2005-2007): Inherited device recalls were among the largest in industry history.
Mesh litigation: Over $1 billion in pelvic mesh settlements resolved through the 2010s.
2026 cyber incident: A cybersecurity outage disrupted manufacturing and cut gross margin 300 basis points in Q3; operations were restored.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Stryker | USA | 1941 | Market leader | Global | All Genders | |
| Becton Dickinson | USA | 1897 | Mass market | Global | All Genders | |
| Ge Healthcare | USA | 2023 | Mass market | Global | All Genders | |
| Stryker | USA | 2004 | Market leader | Global | All Genders | |
| Zimmer Biomet | USA | 2010 | Mass market | Global | All Genders | |
| Stryker | USA | 1971 | Market leader | United states | All Genders |
Healthcare PharmaceuticalsOwned by Stryker Corporation
Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.
Healthcare PharmaceuticalsOwned by Becton, Dickinson and Company
Master brand of Becton, Dickinson and Company, the medical technology company behind Vacutainer, Pyxis, Alaris, and Bard product lines.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Medical imaging equipment brand of GE HealthCare, covering MRI, CT, X-ray, and molecular imaging systems used in hospitals and diagnostic centers worldwide.
Healthcare PharmaceuticalsOwned by Stryker Corporation
Stryker's robotic-arm assisted surgery system for hip and knee replacement, acquired in 2013 and now the leading orthopaedic robotics platform.
Healthcare PharmaceuticalsOwned by Zimmer Biomet Holdings, Inc.
Medical device company focused exclusively on foot and ankle orthopedic surgery. Founded in 2010 and acquired by Zimmer Biomet in 2025 for approximately $1.1 billion.
Healthcare PharmaceuticalsOwned by Stryker Corporation
Patient care and infection prevention brand owned by Stryker since 2016, maker of prepackaged bathing systems, oral care, and skin protection products.
Market Positioning: Boston Scientific competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Boston Scientific Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
Band-Aid is privately owned, unlike Boston Scientific which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Stryker Corporation
Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.
Stryker operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023. Kimberly-Clark is acquiring Kenvue in a deal closed on November 2, 2026.
Tylenol is privately owned, unlike Boston Scientific which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Boston Scientific which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Zocdoc, Inc.
Online healthcare marketplace where patients find in-network doctors and book appointments instantly, a private New York company valued at $1.8 billion.
Zocdoc is privately owned, unlike Boston Scientific which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
Benadryl is privately owned, unlike Boston Scientific which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.